Crossmark

Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics

Crossref DOI link: https://doi.org/10.1016/j.endien.2019.08.004

Published Print: 2019-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Vinagre, Irene

Gerstein, Hertzel

Viñals, Clara

Conget, Ignacio
License Information

Text and Data Mining valid from 2019-08-01
More Information

This article is maintained by: Elsevier

Article Title: Generalizability of results from the recent FDA-guided cardiovascular outcomes trials to a representative population with Type 2 Diabetes attending primary care clinics

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2019.08.004

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2019.01.005

Content Type: simple-article

Copyright: © 2019 SEEN and SED. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below